SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-05-001236
Filing Date
2005-05-05
Accepted
2005-05-05 14:26:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC FILING PREPARED BY SOLUTIONS ATLANTIC REGULATORY REPORTING SYSTEM solutionsatlantic_rrs-filing.htm SC 13G/A 19372
  Complete submission text file 0000902219-05-001236.txt   21524
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 05802940
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 75 STATE STREET BOSTON MA 02109
Business Address 75 STATE STREET BOSTON MA 02109 6179515000
WELLINGTON MANAGEMENT CO LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000